Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study
- PMID: 24164569
- PMCID: PMC3908359
- DOI: 10.1111/jcpe.12155
Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study
Abstract
Aim: The aim of this randomized placebo-controlled clinical trial was to evaluate the effects of Lactobacillus reuteri-containing probiotic lozenges as an adjunct to scaling and root planing (SRP).
Material and methods: Thirty chronic periodontitis patients were recruited and monitored clinically and microbiologically at baseline, 3, 6, 9 and 12 weeks after therapy. All patients received one-stage full-mouth disinfection and randomly assigned over a test (SRP + probiotic, n = 15) or control (SRP + placebo, n = 15) group. The lozenges were used two times a day for 12 weeks.
Results: At week 12, all clinical parameters were significantly reduced in both groups, while there was significantly more pocket depth reduction (p < 0.05) and attachment gain (p < 0.05) in moderate and deep pockets; more Porphyromonas gingivalis reduction was observed in the SRP + probiotic group.
Conclusions: The results indicate that oral administration of L. reuteri lozenges could be a useful adjunct to SRP in chronic periodontitis.
Keywords: Lactobacillus reuteri; microbiology; periodontitis; probiotics; scaling and root planing; treatment.
© 2013 The Authors. Journal of Clinical Periodontology published by John Wiley & Sons Ltd.
Figures
Similar articles
-
Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study.J Clin Periodontol. 2015 Apr;42(4):363-72. doi: 10.1111/jcpe.12387. Epub 2015 Apr 10. J Clin Periodontol. 2015. PMID: 25728888 Clinical Trial.
-
Clinical and Biochemical Evaluation of Lozenges Containing Lactobacillus reuteri as an Adjunct to Non-Surgical Periodontal Therapy in Chronic Periodontitis.J Periodontol. 2015 Jun;86(6):746-54. doi: 10.1902/jop.2015.140612. Epub 2015 Mar 5. J Periodontol. 2015. PMID: 25741580 Clinical Trial.
-
One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin.J Periodontol. 2009 Sep;80(9):1406-13. doi: 10.1902/jop.2009.090067. J Periodontol. 2009. PMID: 19722790 Clinical Trial.
-
Clinical effect of azithromycin as an adjunct to non-surgical treatment of chronic periodontitis: a meta-analysis of randomized controlled clinical trials.J Periodontal Res. 2016 Jun;51(3):275-83. doi: 10.1111/jre.12319. Epub 2015 Sep 12. J Periodontal Res. 2016. PMID: 26362529 Review.
-
Lactobacillus reuteri for chronic periodontitis: focus on underlying mechanisms and future perspectives.Biotechnol Genet Eng Rev. 2024 Apr;40(1):381-408. doi: 10.1080/02648725.2023.2183617. Epub 2023 Mar 1. Biotechnol Genet Eng Rev. 2024. PMID: 36856460 Review.
Cited by
-
Probiotics, tetracycline fibres and chlorhexidine gel's effectiveness in treating chronic periodontitis as a supplement to scaling and root planning.Bioinformation. 2024 Aug 31;20(8):933-937. doi: 10.6026/973206300200933. eCollection 2024. Bioinformation. 2024. PMID: 39411761 Free PMC article.
-
Probiotics in the non-surgical treatment of periodontitis: a systematic review and network meta-analysis.BMC Oral Health. 2024 Oct 15;24(1):1224. doi: 10.1186/s12903-024-05027-6. BMC Oral Health. 2024. PMID: 39407177 Free PMC article.
-
Microbiological and clinical effects of probiotic-related Zeger therapy on gingival health: a randomized controlled clinical trial.BMC Oral Health. 2024 Sep 14;24(1):1086. doi: 10.1186/s12903-024-04846-x. BMC Oral Health. 2024. PMID: 39277730 Free PMC article. Clinical Trial.
-
Strategies and mechanisms targeting Enterococcus faecalis biofilms associated with endodontic infections: a comprehensive review.Front Cell Infect Microbiol. 2024 Jul 18;14:1433313. doi: 10.3389/fcimb.2024.1433313. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39091674 Free PMC article. Review.
-
Smoking Impacts Alzheimer's Disease Progression Through Oral Microbiota Modulation.Mol Neurobiol. 2024 May 25. doi: 10.1007/s12035-024-04241-1. Online ahead of print. Mol Neurobiol. 2024. PMID: 38795302 Review.
References
-
- Adams CA. The probiotic paradox: live and dead cells are biological response modifiers. Nutritional Research Reviews. 2010;23:37–46. - PubMed
-
- Boutaga K, van Winkelhoff AJ, Vandenbroucke-Grauls CM, Savelkoul PH. Periodontal pathogens: a quantitative comparison of anaerobic culture and real-time PCR. FEMS Immunology and Medical Microbiology. 2005;45:191–199. - PubMed
-
- Broekaert IJ, Walker WA. Probiotics and chronic disease. Journal of Clinical Gastroenterology. 2006;40:270–274. - PubMed
-
- Caglar E, Topcuoglu N, Cildir SK, Sandalli N, Kulekci G. Oral colonization by Lactobacillus reuteri ATCC 55730 after exposure to probiotics. International Journal of Paediatric Dentistry. 2009;19:377–381. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources